Stockscreener 앱 받기
1.07
4.04%
-0.045
시간 외 거래:
1.07
전일 마감가:
$1.115
열려 있는:
$1.11
하루 거래량:
592.51K
Relative Volume:
0.38
시가총액:
$455.79M
수익:
$106.34M
순이익/손실:
$-74.66M
주가수익비율:
-1.1263
EPS:
-0.95
순현금흐름:
$-46.12M
1주 성능:
-10.83%
1개월 성능:
-7.76%
6개월 성능:
-50.23%
1년 성능:
-55.60%
1일 변동 폭
$1.06
$1.135
1주일 범위
$0.9521
$1.22
52주 변동 폭
$0.9521
$2.74
Standard Biotools Inc Stock (LAB) Company Profile
명칭
Standard Biotools Inc
전화
(650) 266-6000
주소
2 TOWER PLACE, SOUTH SAN FRANCISCO
LAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.07 | 455.79M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-27 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | 개시 | TD Cowen | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-12 | 개시 | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc 주식(LAB)의 최신 뉴스
Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships - MSN
Before You Sell Standard BioTools Inc (NASDAQ: LAB) Shares, Here’sWhat You Need To Know. - Stocksregister
Standard BioTools First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
MetLife Investment Management LLC Purchases 40,057 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. Earnings Call: Mixed Outlook Amid Challenges - TipRanks
Standard BioTools Inc. (NASDAQ:LAB) Q1 2025 Earnings Call Transcript - Insider Monkey
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Standard BioTools Inc (LAB) Q1 2025 Earnings Call Highlights: Na - GuruFocus
Standard BioTools: Q1 Earnings Snapshot - CTPost
Standard BioTools Shows Resilience Amid Revenue Decline - TipRanks
Standard BioTools Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:LAB) - Seeking Alpha
Earnings call transcript: Standard Biotools reports Q1 2025 loss, stock dips - Investing.com
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Standard BioTools Q1 2025 Financial Results Overview - TipRanks
Standard BioTools Inc (LAB) Q1 2025 Earnings: EPS of -$0.07 Beats Estimate, Revenue of $40.8M Exceeds Expectations - GuruFocus
Standard BioTools (LAB) Exceeds Q1 Revenue Estimates with Strong Performance | LAB Stock News - GuruFocus
STANDARD BIOTOOLS Earnings Results: $LAB Reports Quarterly Earnings - Nasdaq
Standard BioTools Q1 2025 slides: revenue falls 10% as company advances cost-cutting - Investing.com
Standard BioTools Reports First Quarter 2025 Financial Results - The Manila Times
Market Recap: Standard BioTools Inc (LAB)’s Negative Momentum, Closing at 1.15 - DWinneX
Standard BioTools Q1 2025 Earnings Preview - MSN
Wells Fargo & Company MN Has $317,000 Stock Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc (LAB) Q1 2025 Earnings Report Preview: Wha - GuruFocus
Standard BioTools Inc (LAB) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
Invesco Ltd. Acquires 12,194 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Standard BioTools Inc (LAB) requires closer examination - uspostnews.com
Standard BioTools cut to Neutral at KeyBanc on guidance - MSN
Standard BioTools Inc [LAB] Stock bought by Insider Casdin Partners Master Fund, L for $5.13 million - knoxdaily.com
Legal & General Group Plc Cuts Position in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Stock Performance Spotlight: Standard BioTools Inc (LAB) Ends the Day at 1.16, Down by -5.69 - DWinneX
Standard BioTools Inc [LAB] Records 50-Day SMA of $1.1772 - knoxdaily.com
Standard BioTools (LAB) Introduces Advanced Proteomic Products a - GuruFocus
Standard BioTools Inc (LAB)’s stock price in review: A technical analysis - uspostnews.com
Standard BioTools Inc (LAB) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 - The Manila Times
Standard BioTools Inc. Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025 - marketscreener.com
Standard BioTools Unveils Game-Changing 3.7K Protein Assay: 4X Faster Analysis Transforms Cancer Research - Stock Titan
Analysts Advise You To Maintain Your Position In Standard BioTools Inc (NASDAQ: LAB) - Stocksregister
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025 - The Manila Times
Standard BioTools Inc. to Announce First Quarter 2025 Financial Results on May 6, 2025 - Nasdaq
Standard BioTools Earnings Preview: Key Q1 2025 Updates Coming May 6What to Watch - Stock Titan
Standard BioTools Inc. (NASDAQ:LAB) Shares Acquired by Geode Capital Management LLC - Defense World
Positive week for Standard BioTools Inc. (NASDAQ:LAB) institutional investors who lost 58% over the past year - simplywall.st
Vanguard Group Inc. Decreases Stake in Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard BioTools Inc. (NASDAQ:LAB) Shares Bought by American Century Companies Inc. - Defense World
Corebridge Financial Inc. Sells 11,070 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
40,166 Shares in Standard BioTools Inc. (NASDAQ:LAB) Acquired by KLP Kapitalforvaltning AS - Defense World
Major Improvements In Standard BioTools Inc (LAB) Stock Need To Be Considered - stocksregister.com
Commonwealth Equity Services LLC Sells 51,993 Shares of Standard BioTools Inc. (NASDAQ:LAB) - Defense World
Standard Biotools Inc (LAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
0.79%
자본화:
|
볼륨(24시간):